Depression studies

Home-based Baduanjin exercise for improving depressive symptoms in older adults

This study isn't currently recruiting.

Countries

China

Sponsor

North University of China

ASSESSING TOLERABILITY AND EFFICACY OF VORTIOXETINE VERSUS SSRIs IN ELDERLY PATIENTS WITH DEPRESSION: A PRAGMATIC, MULTICENTER, OPEN-LABEL, PARALLEL-GROUP, SUPERIORITY, RANDOMIZED TRIAL

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Italy

Sponsor

AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

Effects of allopregnanolone in women with PMDD, depression, PCOS och oral contraceptives

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Sweden

Sponsor

Norrlands university hospital

Efficacy and safety of agomelatine oral administration (25 to 50 mg/day) in elderly patients suffering from Major Depressive Disorder. A 8-week, randomised, double-blind, flexible-dose, parallel gr...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Finland, Portugal

Sponsor

Institut de Recherches Internationales Servier

Efficacy of Tranylcypromine (TCP) in daily doses up to 60mg and lithiumaugmentation (Li.-Aug.) of antidepressants inn the acute treatmet of therapy-resistant Depression. An open randomized study in...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Charité Universitätsmedizin Berlin

Functional Neuroimaging in depression: longitudinal study of PET metabolism in correlation with changes in attentional bias, autobiographical memory, future fluency and facial recognition in depres...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Belgium

Sponsor

University Hospital Ghent

Investigating N-methyl-d-aspartate (NMDA) receptor alterations in major depressive disorder by brain PET

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria

Sponsor

Medical University of Vienna, University Department of Psychiatry and Psychotherapy

Ketamine augmentation of ECT to improve outcomes in depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

Manchester Mental Health and Social Care Trust

Open-label, Multicenter Clinical Study of Dose-dependent Efficacy and Safety of Trazodone Hydrochloride in Patients wirh Major Depressive Disorder ans Pain (TIPAD Study)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria

Sponsor

CSC Pharmaceuticals Handels GmbH.

Prevention of depression and poor physical function in older persons with vitamin D supplementation

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Netherlands

Sponsor

VU University Medical Centre

Study of efficacy of low-dose recombinant human interleukin-2 in immunological changes associated with depression (IL2REG)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Italy

Sponsor

OSPEDALE SAN RAFFAELE

Agomelatine treatment of major depressive episodes in the course of schizophrenic psychoses (AGOPSYCH). A single arm, prospective pilot study

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Central Institute of Mental Health, Department of Psychiatry and Psychotherapy